Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cryoviva Singapore is a private family cord blood and cord tissue stem cell bank operating in Singapore. The company provides end-to-end services including collection, processing, infectious disease and safety testing, cryopreservation, and long-term storage of newborn stem cell samples for potential future therapeutic use. Its Singapore laboratory is Ministry of Health licensed, AABB accredited, and positioned as part of Cryoviva's broader international network. In addition to routine banking services, the company has supported release of stored autologous cord blood units for clinical use and participation in a KK Women's and Children's Hospital autism study. Cryoviva Singapore is best understood as a commercial healthcare services and biobanking business rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cryoviva Singapore.